Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2026-06-30 @ 9:29 PM
Study NCT ID:
NCT00485758
Status:
COMPLETED
Last Update Posted:
2015-10-12
First Post:
2007-06-12
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Extended Niacin/Laropiprant in Patients With Type 2 Diabetes (0524A-069)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Diabetes Mellitus Type 2 | View |
Keywords: